Healthcare Technology Report May 29, 2024
The U.S. FDA, Environmental Protection Agency, and Department of Agriculture have responded to President Biden’s call by unveiling a comprehensive plan to overhaul biotech regulations. Prompted by Executive Order 14081, issued in September 2022, the plan aims to modernize regulations surrounding the development and manufacture of biotech products, from industrial goods to CRISPR technologies. Stakeholder feedback, including input from industry groups and public commentary, has shaped the plan, highlighting the need for clarity, synchronization, and updates to existing regulations.
Future policy initiatives outlined in...